Since its inception, MSCRF has invested over $170 million in over 500 projects to accelerate stem cell research, commercialization, and cures. With a 2023 fiscal year budget of $20.5M, MSCRF offers six funding opportunities to scientists and companies in the areas of clinical trials, discovery, commercialization, validation, launch, and post-doctoral fellowships. The fund has supported the creation and growth of many stem cell companies since launching the Accelerating Cures initiative in 2017.
Top Stem Cell Companies Supported by the Maryland Stem Cell Research Fund
![](https://biobuzz.io/wp-content/uploads/2019/04/MSCRF-stemcell-300x300.png)